Compare LSTR & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LSTR | STVN |
|---|---|---|
| Founded | 1988 | 1949 |
| Country | United States | Italy |
| Employees | N/A | 5795 |
| Industry | Trucking Freight/Courier Services | Containers/Packaging |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.7B |
| IPO Year | 1994 | 2021 |
| Metric | LSTR | STVN |
|---|---|---|
| Price | $172.08 | $21.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 3 |
| Target Price | ★ $173.83 | $25.67 |
| AVG Volume (30 Days) | 305.9K | ★ 367.1K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.95% | 0.39% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | ★ $4,743,760,000.00 | N/A |
| Revenue This Year | $6.89 | $9.67 |
| Revenue Next Year | $9.05 | $9.99 |
| P/E Ratio | $149.63 | ★ $27.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $119.40 | $12.89 |
| 52 Week High | $228.46 | $28.00 |
| Indicator | LSTR | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 37.75 | 48.70 |
| Support Level | $167.58 | $20.17 |
| Resistance Level | $174.75 | $22.00 |
| Average True Range (ATR) | 4.89 | 0.78 |
| MACD | -0.13 | -0.24 |
| Stochastic Oscillator | 14.88 | 29.36 |
Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.